Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells (Q36823732)
Jump to navigation
Jump to search
scientific article published on 10 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells |
scientific article published on 10 March 2016 |
Statements
1 reference
Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells (English)
1 reference
Susan P Foy
1 reference
Stefanie J Mandl
1 reference
Tracy dela Cruz
1 reference
Joseph J Cote
1 reference
Evan J Gordon
1 reference
Erica Trent
1 reference
Alain Delcayre
1 reference
James Breitmeyer
1 reference
Alex Franzusoff
1 reference
Ryan B Rountree
1 reference
10 March 2016
1 reference
1 reference
537-549
1 reference
10 March 2016
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference